Bictegravir, emtricitabine, and tenofovir alafenamide versus dolutegravir, emtricitabine, and tenofovir disoproxil fumarate for initial treatment of HIV-1 and hepatitis B coinfection (ALLIANCE): a double-blind, multicentre, randomised controlled, phase 3 non-inferiority trial

Bictegravir, emtricitabine, and tenofovir alafenamide versus dolutegravir, emtricitabine, and tenofovir disoproxil fumarate for initial treatment of HIV-1 and hepatitis B coinfection (ALLIANCE): a double-blind, multicentre, randomised controlled, phase 3 non-inferiority trial https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(23)00151-0/fulltext?dgcid=hubspot_email_conferencealerts_ias2023&utm_campaign=conferencealerts&utm_medium=email&_hsmi=267220001&_hsenc=p2ANqtz--dOe5fGY1gqwIjSJlte1yMe8ysxUpVXoEyi6ZV-y7BHD7vK1IbYkiDUfUBv1qsa8jpdGlCczeY0-W2eBBIHEIBWuRcsw&utm_content=267220001&utm_source=hs_email